Kymera Therapeutics KYMR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's total current assets?
- Kymera Therapeutics (KYMR) reported total current assets of $677.43M in Q1 2026.
- How has Kymera Therapeutics's total current assets changed year-over-year?
- Kymera Therapeutics's total current assets increased by 35.2% year-over-year, from $500.95M to $677.43M.
- What is the long-term trend for Kymera Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Kymera Therapeutics's total current assets has grown at a 23.6% compound annual growth rate (CAGR), from $302.34M to $871.21M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.